Indivior, Inc., a leading global pharmaceutical company headquartered in the United States, is dedicated to transforming the treatment of addiction and related disorders. Founded in 2014, Indivior has established itself as a key player in the addiction treatment industry, focusing on innovative therapies that address opioid dependence and other substance use disorders. With a strong presence in North America and Europe, Indivior's core products, including SUBOXONE® and SUBLOCADE®, are designed to provide effective, long-term solutions for patients. These unique formulations not only enhance patient adherence but also contribute to reducing the stigma associated with addiction treatment. Recognised for its commitment to patient care and public health, Indivior continues to make significant strides in the market, positioning itself as a trusted partner in the fight against addiction.
We don't have data for Indivior, Inc., but we can show you information about their parent organization instead.
View parent company